India to United States: Ondansetron Export Trade Route
India has recorded 1,450 verified shipments of Ondansetron exported to United States, representing a combined trade value of $47.9M USD. This corridor is served by 22 active Indian exporters, with an average shipment value of $33.1K USD. The leading Indian exporter is AUROBINDO PHARMA LTD, which accounts for 33% of total export value with 386 shipments worth $15.8M USD. On the buying side, NORTHSTAR DISTRIBUTION CENTER 8912 is the largest importer in United States with $4.0M USD in purchases. The top 3 suppliers — AUROBINDO PHARMA LTD, GLENMARK PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LIMITED — together control 74% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Ondansetron corridor is one of India's established pharmaceutical export routes, with 1,450 shipments documented worth a combined $47.9M USD. The route is dominated by AUROBINDO PHARMA LTD, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's ondansetron manufacturing sector.
Across 22 active suppliers, the average shipment value stands at $33.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 24.4%, placing it at rank #12 among India's top ondansetron export destinations globally.
On the import side, key buyers of Indian ondansetron in United States include NORTHSTAR DISTRIBUTION CENTER 8912, GLENMARK PHARMACEUTICALS INC USA, AUROLOGISTICS LLC (AUROBINDO PHARMA and 116 others. NORTHSTAR DISTRIBUTION CENTER 8912 is the single largest importer with 122 shipments valued at $4.0M USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portHYDERABAD ICD
Market Position
- Global rank#12
- Annual growth+24.4%
- Demand growth+20.6%
- Regulatory ease66/100
Top 10 Indian Ondansetron Exporters to United States
Showing top 10 of 22 Indian suppliers exporting Ondansetron to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD Avg $40.8K per shipment | 386 | $15.8M | 32.9% |
| 2 | GLENMARK PHARMACEUTICALS LIMITED Avg $22.3K per shipment | 469 | $10.5M | 21.8% |
| 3 | AUROBINDO PHARMA LIMITED Avg $44.8K per shipment | 209 | $9.4M | 19.5% |
| 4 | GLAND PHARMA LIMITED Avg $50.5K per shipment | 71 | $3.6M | 7.5% |
| 5 | GLAND PHARMA LTD Avg $41.4K per shipment | 82 | $3.4M | 7.1% |
| 6 | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED Avg $55.8K per shipment | 23 | $1.3M | 2.7% |
| 7 | DR.REDDY'S LABORATORIES LTD Avg $30.3K per shipment | 36 | $1.1M | 2.3% |
| 8 | NATCO PHARMA LIMITED Avg $27.0K per shipment | 35 | $946.7K | 2.0% |
| 9 | DR REDDYS LABORATORIES LIMITED Avg $33.7K per shipment | 27 | $911.1K | 1.9% |
| 10 | GLENMARK PHARMACEUTICALS LTD Avg $32.5K per shipment | 24 | $780.7K | 1.6% |
This table shows the top 10 of 22 Indian companies exporting ondansetron to United States, ranked by total trade value. The listed exporters are: AUROBINDO PHARMA LTD, GLENMARK PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LIMITED, GLAND PHARMA LIMITED, GLAND PHARMA LTD, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, DR.REDDY'S LABORATORIES LTD, NATCO PHARMA LIMITED, DR REDDYS LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LTD. AUROBINDO PHARMA LTD is the dominant supplier with 386 shipments worth $15.8M USD, giving it a 33% market share. The top 3 suppliers together account for 74% of the total trade value on this route.
Showing top 10 of 22 total Indian exporters on the India to United States Ondansetron export route.
Top 10 Ondansetron Importers in United States
Showing top 10 of 119 known buyers in United States receiving Ondansetron shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ondansetron in United States include NORTHSTAR DISTRIBUTION CENTER 8912, GLENMARK PHARMACEUTICALS INC USA, AUROLOGISTICS LLC (AUROBINDO PHARMA, GLENMARK PHARMACEUTICALS INC., USA, RISING PHARMA HOLDINGS, INC., among 119 total buyers. The largest importer is NORTHSTAR DISTRIBUTION CENTER 8912, accounting for $4.0M USD across 122 shipments — representing 8% of all ondansetron imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NORTHSTAR DISTRIBUTION CENTER 8912 | 122 | $4.0M | 8.4% |
| 2 | GLENMARK PHARMACEUTICALS INC USA | 125 | $3.9M | 8.1% |
| 3 | AUROLOGISTICS LLC (AUROBINDO PHARMA | 52 | $3.6M | 7.6% |
| 4 | GLENMARK PHARMACEUTICALS INC., USA | 186 | $3.6M | 7.6% |
| 5 | RISING PHARMA HOLDINGS, INC. | 157 | $3.4M | 7.1% |
| 6 | AVET PHARMACEUTICALS INC | 67 | $3.0M | 6.2% |
| 7 | AUROLOGISTICS LLC AUROBINDO PHARM | 30 | $2.8M | 5.9% |
| 8 | RISING PHARMA HOLDINGS INC | 61 | $2.4M | 5.1% |
| 9 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 32 | $2.3M | 4.7% |
| 10 | EVERSANA LIFE SCIENCE SERVICES | 48 | $2.1M | 4.4% |
Showing top 10 of 119 Ondansetron importers in United States on this route.
Top 10 Ondansetron Formulations Imported by United States
Showing top 10 of 615 product formulations shipped on the India to United States Ondansetron route, ranked by trade value
United States imports a wide range of ondansetron formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ONDANSETRON ODT 4MG 30UD — accounts for $4.3M USD across 174 shipments. There are 615 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ONDANSETRON ODT 4MG 30UD | 174 | $4.3M | 8.9% |
| 2 | ONDANSETRON INJECTION USP 40MG/20ML VIAL(2MG/ML) | 24 | $1.3M | 2.7% |
| 3 | ONDANSETRON ORALLY DISINTEGRATING TABLETS 4MG (115200X30'S) | 26 | $1.1M | 2.2% |
| 4 | ONDANSETRON ORALLY DISINTEGRATING TABLET | 17 | $812.4K | 1.7% |
| 5 | ONDANSETRON HCL TABLETS 4MG (ONDANSETRON | 9 | $744.0K | 1.6% |
| 6 | ONDANSETRON INJECTION USP 2MG/ML,2ML VIAL(25#S PACK ) | 15 | $671.3K | 1.4% |
| 7 | ONDANSETRON ORALLY DISINTEGRATING TABLETS 4MG 3X10'S (ONDANSETRON ORALLY DISINTEGRATING | 9 | $654.1K | 1.4% |
| 8 | ONDANSETRON ORALLY DISINTEGRATING TABLET | 13 | $597.8K | 1.2% |
| 9 | ONDANSETRON HCL TABLETS 4MG (ONDANSETRONTABLETS USP 4MG) 30'S | 9 | $577.4K | 1.2% |
| 10 | ONDANSETRON HCL TABLETS 4MG (ONDANSETRONORALLY DISINTEGRATING TABLETS USP 4MG)(115200X3X10'S PACK) | 10 | $456.3K | 1.0% |
Showing top 10 of 615 Ondansetron formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 348 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's ondansetron exports to United States are driven primarily by a handful of large-scale manufacturers. AUROBINDO PHARMA LTD with 386 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 22 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AUROBINDO PHARMA LTD, GLENMARK PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LIMITED — together account for 74% of total trade value on this route. The average shipment value of $33.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ondansetron injection usp 40mg/20ml vial(2mg/ml) and ondansetron orally disintegrating tablets 4mg (115200x30's), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NORTHSTAR DISTRIBUTION CENTER 8912 is the largest importer with 122 shipments worth $4.0M USD — representing 8% of all ondansetron imports from India on this route. A total of 119 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $47.9M
- Avg. Shipment
- $33.1K
- Suppliers
- 22
- Buyers
- 119
- Transit (Sea)
- ~29 days
- Annual Growth
- +24.4%
Related Analysis
Reverse Direction
United States → India — Ondansetron (Import)Other Ondansetron Routes
Unlock the Full India to United States Ondansetron Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1,450 shipments on this route.
Frequently Asked Questions — India to United States Ondansetron Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ondansetron to United States?
The leading Indian exporters of Ondansetron to United States are AUROBINDO PHARMA LTD, GLENMARK PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LIMITED. AUROBINDO PHARMA LTD holds the largest market share at approximately 33% of total trade value on this route.
Q What is the total value of Ondansetron exports from India to United States?
India exports Ondansetron to United States worth approximately $47.9M USD across 1,450 recorded shipments. The average value per shipment is $33.1K USD.
Q Which ports does India use to ship Ondansetron to United States?
The most active port of origin is HYDERABAD ICD with 348 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to United States for Ondansetron?
The average transit time for Ondansetron shipments from India to United States is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Ondansetron trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 24.4% with demand growth tracking at 20.6%. The route is ranked #12 among India's top Ondansetron export destinations globally.
Q How many suppliers are active on the India to United States Ondansetron route?
There are currently 22 active Indian suppliers exporting Ondansetron to United States. The market is moderately concentrated with AUROBINDO PHARMA LTD accounting for 33% of total shipment value.
Q Who are the main importers of Ondansetron from India in United States?
The leading importers of Indian Ondansetron in United States include NORTHSTAR DISTRIBUTION CENTER 8912, GLENMARK PHARMACEUTICALS INC USA, AUROLOGISTICS LLC (AUROBINDO PHARMA, GLENMARK PHARMACEUTICALS INC., USA, RISING PHARMA HOLDINGS, INC.. NORTHSTAR DISTRIBUTION CENTER 8912 is the largest buyer with 122 shipments worth $4.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Ondansetron.
- 2.Supplier/Buyer Matching: 22 Indian exporters and 119 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1,450 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,450 Verified Shipments
22 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists